BEIJING (Reuters) - China is tightening application procedures for firms seeking to manufacture drugs, state media reported on Monday, following a rash of scandals over fake medicines and corruption in the industry. The higher threshold to qualify for Good Manufacturing Practice (GMP) certification will take effect on January 1.
